On June 30, the transfers of value from the pharmaceutical and medical device industry to the healthcare industry have been disclosed on This is already the third disclosure of collaborations under the legal framework of the Sunshine Act.

A total of 623 pharmaceutical and medical technology companies submitted data relating to the year 2019. Together they invested a total of 248,422,100 euros in 2019 in collaborations with healthcare providers, healthcare institutions and patient associations active in Belgium.


Share This